You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recombinant human endostatin

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Mucosal Melanoma Trial (Envafolimab combined with recombinant human endostatin and first-line chemo)

Not yet recruiting
  • Advanced Mucosal Melanoma
  • Envafolimab combined with recombinant human endostatin and first-line chemotherapy
  • (no location specified)
Sep 15, 2023

Nasopharyngeal Carcinoma Trial (Envafolimab and recombinant human endostatin combined with chemoradiotherapy)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Envafolimab and recombinant human endostatin combined with chemoradiotherapy
  • (no location specified)
Sep 23, 2023

Colorectal Tumors Trial (Envafolimab, recombinant human endostatin (endostatin))

Not yet recruiting
  • Colorectal Neoplasms
  • (no location specified)
Sep 19, 2022

Leptomeningeal Metastasis, Immune Checkpoint Inhibitor, Endostatin Trial in Hebei (Camrelizumab or envafolimab)

Recruiting
  • Leptomeningeal Metastasis
  • +2 more
  • Camrelizumab or envafolimab
  • Hebei, China
    The Second Hospital of Hebei Medical University
May 19, 2022

Squamous NSCLC Trial in Jinan ("Envafolimab" and "Chemotherapy" and "Recombinant Human Endostatin")

Recruiting
  • Squamous Non-small Cell Lung Cancer
  • "Envafolimab" and "Chemotherapy" and "Recombinant Human Endostatin"
  • Jinan, Shandong, China
  • +1 more
Feb 14, 2022

Non-Small-Cell Lung Cancer Trial in Jinan (Recombinant human endostatin (Endostar))

Recruiting
  • Non-Small-Cell Lung Cancer
  • Recombinant human endostatin (Endostar)
  • Jinan, Shandong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Oct 8, 2022

NSCLC Trial in Changsha (envafolimab)

Enrolling by invitation
  • Non-small Cell Lung Cancer
  • Changsha, Hunan, China
    the second Xiangya hospital
May 1, 2022

Nasopharyngeal Carcinoma Trial in China (Endostatin and Capecitabine)

Recruiting
  • Nasopharyngeal Carcinoma
  • Endostatin and Capecitabine
  • Hangzhou, Zhejiang, China
  • +6 more
Aug 21, 2022

Low-grade Glioma, Pediatric Brain Tumor Trial in Beijing (combined therapy with rh-ES and CV)

Recruiting
  • Low-grade Glioma
  • Pediatric Brain Tumor
  • combined therapy with rh-ES and CV
  • Beijing, China
    Capital Medical University Sanbo Brain Hospital
Feb 10, 2022

Envafolimab Combined With Endostar and Concurrent

Not yet recruiting
  • Cervical Cancer
  • (no location specified)
May 19, 2023

Optic Glioma, Pediatric Brain Tumor, Optic Nerve Glioma Trial in Beijing (Carboplatin, Vincristine, Recombinant human

Recruiting
  • Optic Glioma
  • Pediatric Brain Tumor, Optic Nerve Glioma
  • Beijing, China
    Capital Medical University Sanbo Brain Hospital
Jul 4, 2022

Non Small Cell Lung Cancer, Endostatin Trial in Guangzhou (Endostatin)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Endostatin
  • Guangzhou, Guangdong, China
    Affiliated Cancer Hospital and Institute of Guangzhou Medical Un
Jul 4, 2022

Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage

Recruiting
  • Advanced Solid Tumor
  • Refractory Tumor
  • Radiotherapy
  • +4 more
  • Suzhou, China
    The Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023

Other Disorders of Soft Tissues Trial in Shanghai (Endostar (recombinant human endostatin injection), Chemotherapy AI)

Recruiting
  • Other Disorders of Soft Tissues
  • Endostar (recombinant human endostatin injection)
  • Chemotherapy AI
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 6, 2021

Leptomeningeal Metastasis Trial (Recombinant Human Endostatin, intrathcal methotrexate, Targeted drugs for non-small cell lung

Not yet recruiting
  • Leptomeningeal Metastasis
  • Recombinant Human Endostatin
  • +2 more
  • (no location specified)
May 23, 2020

Advanced or Metastatic NSCLC Trial in Shanghai (drug, device, combination product)

Not yet recruiting
  • Advanced or Metastatic NSCLC
  • Shanghai, Shanghai, China
    Lan Mu
Jun 29, 2021

Lung Cancer Trial (Recombinant human endostatin (Endostar), Thoracic irradiation of 50 Gy with 3DCRT or IMRT)

Not yet recruiting
  • Lung Cancer
  • Recombinant human endostatin (Endostar)
  • Thoracic irradiation of 50 Gy with 3DCRT or IMRT
  • (no location specified)
Oct 27, 2020

Esophageal Trial in Nanjing ("Endostar", Liposo, cisplatin)

Terminated
  • Esophageal
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jul 28, 2022

Hepatic Ascites Trial in Guangdong (Recombinant Human Serum Albumin, Human serum albumin)

Not yet recruiting
  • Hepatic Ascites
  • Recombinant Human Serum Albumin
  • Human serum albumin
  • Guangdong, Shenzhen, China
    Shenzhen Protgen Ltd
May 5, 2023

Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

Enrolling by invitation
  • Malignant Melanomas
  • Recombinant Human Adenovirus Type 5 Injection
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
Jul 7, 2023

Advanced Solid Tumors Trial in Hangzhou, Shanghai (Recombinant human IL-21 oncolytic vaccinia virus injection)

Not yet recruiting
  • Advanced Solid Tumors
  • Recombinant human IL-21 oncolytic vaccinia virus injection
  • Hangzhou, Zhejiang, China
  • +1 more
Jun 21, 2023

Norovirus Infections, Norwalk Gastroenteritis Trial (Human Norovirus Bivalent (G?.1/G?.4)Vaccine,Recombinant (Hansenula

Not yet recruiting
  • Norovirus Infections
  • Norwalk Gastroenteritis
  • Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula polymorpha)
  • placebo
  • (no location specified)
Jun 14, 2023

Solid Tumor Trial in Madison (recombinant human endostatin)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • recombinant human endostatin
  • Madison, Wisconsin
    University of Wisconsin Comprehensive Cancer Center
Dec 12, 2019

Herpes Zoster Trial (Recombinant Human Interferon a-2b Gel (After the Alteration), Recombinant Human Interferon a-2b Gel (Before

Not yet recruiting
  • Herpes Zoster
  • Recombinant Human Interferon α-2b Gel (After the Alteration)
  • Recombinant Human Interferon α-2b Gel (Before the Alteration)
  • (no location specified)
Apr 7, 2023

Viral Upper Respiratory Tract Infection Trial (recombinant human interferon ? spray)

Not yet recruiting
  • Viral Upper Respiratory Tract Infection
  • recombinant human interferon ω spray
  • (no location specified)
May 7, 2023